CDL Drug Testing in Pennsylvania 2026: DOT Rules and Clearinghouse
How DOT drug and alcohol testing applies to Pennsylvania CDL drivers, including the federal five-drug panel, Clearinghouse status, and return-to-duty process.
Pennsylvania CDL holders working in DOT-regulated safety-sensitive driving positions follow the federal drug and alcohol testing framework. Pennsylvania does not substitute a different CDL-specific drug panel for the federal program.
What the DOT drug panel covers
The federal DOT panel tests for five drug classes: marijuana, cocaine, amphetamines/methamphetamines, opioids/opiates, and PCP. Employers may have additional workplace policies, but a DOT test must follow the federal collection, laboratory, review, and reporting rules.
Testing is not limited to hiring
- Pre-employment testing before covered safety-sensitive driving.
- Random testing.
- Post-accident testing when federal criteria apply.
- Reasonable-suspicion testing.
- Return-to-duty testing after a violation.
- Follow-up testing after the driver returns to safety-sensitive work.
Clearinghouse status follows the driver
A DOT drug or alcohol violation can place a driver in prohibited status in the FMCSA Drug & Alcohol Clearinghouse. Under the current Clearinghouse-II system, a prohibited status can affect state CDL or CLP privileges, not just the driver’s relationship with one employer.
Return-to-duty cannot be skipped
The federal process generally requires evaluation by a qualified Substance Abuse Professional, completion of prescribed education or treatment, a successful return-to-duty test, and a follow-up testing plan. Changing employers does not erase that process.
Marijuana and state law
Pennsylvania law or medical-use status does not override the federal DOT prohibition for safety-sensitive commercial drivers. DOT-regulated marijuana testing remains governed by federal transportation law.
Sources: PennDOT commercial-driver resources; FMCSA Drug & Alcohol Clearinghouse; 49 CFR Part 40. Reviewed October 2026.